Literature DB >> 15336402

The interaction of Pseudomonas aeruginosa PAK with human and animal respiratory tract cell lines.

Joy Hambrook1, Richard Titball, Christopher Lindsay.   

Abstract

A major virulence factor of a common human pathogen Pseudomonas aeruginosa, was investigated to determine if it dominated attachment interactions in a variety of in vitro cell culture systems. It was found that Type-IV pilus-type mechanisms, which mediated the attachment of P. aeruginosa to three human respiratory tract cell lines (A549, BEAS-2B and RPMI 2650) also mediated attachment to two respiratory tract cell lines from mouse (C57) and rat (L-2) to a similar degree. Significant differences were found in the number of P. aeruginosa associated with the human, rat and mouse cell lines. Additionally, differences were also found between A547, C57 and L-2 cells with respect to the moieties that P. aeruginosa interacted with at the level of the cell surface, suggesting that asialo-GM1 ligands were not the only structure that this bacterium could interact with in order to associate with host cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336402     DOI: 10.1016/j.femsle.2004.07.016

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

1.  The Psa fimbriae of Yersinia pestis interact with phosphatidylcholine on alveolar epithelial cells and pulmonary surfactant.

Authors:  Estela M Galván; Huaiqing Chen; Dieter M Schifferli
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

2.  Potential source of Francisella tularensis live vaccine strain attenuation determined by genome comparison.

Authors:  Laurence Rohmer; Mitchell Brittnacher; Kerstin Svensson; Danielle Buckley; Eric Haugen; Yang Zhou; Jean Chang; Ruth Levy; Hillary Hayden; Mats Forsman; Maynard Olson; Anders Johansson; Rajinder Kaul; Samuel I Miller
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

Review 3.  Receptor mimicry as novel therapeutic treatment for biothreat agents.

Authors:  Richard J Thomas
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.